Long-Term Outcomes Following Cochlear Implantation: Device "Aging" and Hearing Performance.

Davide Soloperto, Gennaro Confuorto, Virginia Dallari, Luca Sacchetto, Marco Carner, Daniele Monzani, Riccardo Nocini
Author Information
  1. Davide Soloperto: Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Modena, 41125 Modena, Italy.
  2. Gennaro Confuorto: Department of Otolaryngology-Head and Neck Surgery, Sassuolo Hospital, AUSL Modena, 41049 Sassuolo, Italy. ORCID
  3. Virginia Dallari: Department of Otolaryngology-Head and Neck Surgery, Santa Maria delle Croci Hospital, AUSL della Romagna, 48121 Ravenna, Italy. ORCID
  4. Luca Sacchetto: Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, 37134 Verona, Italy.
  5. Marco Carner: Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, 37134 Verona, Italy.
  6. Daniele Monzani: Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, 37134 Verona, Italy. ORCID
  7. Riccardo Nocini: Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, 37134 Verona, Italy.

Abstract

PURPOSE: The purpose of this study was to evaluate the clinical and audiological outcomes in long-term cochlear implant (CI) users, focusing on hearing performance and device failures.
METHODS: A retrospective study was conducted on patients who underwent CI surgery, with a minimum follow-up of 10 years. Device survival was analyzed using Kaplan-Meier curves, and failure rates were classified as device failure explants or medical-related explants. The time to revision and causes of reimplantation were assessed. Statistical analyses included Pearson correlation for audiological outcomes, Student's -test for group comparisons, and the log-rank test for survival comparisons among implant brands.
RESULTS: In this study, data from a total of 211 CIs were collected. Fourteen major postoperative complications were reported in this series, resulting in a global major complication rate of 6.6%: 5.2% due to hard failure and 1.4% due to medical problems and soft failure. The revision rate was 4.1% for the children's group and 10% for the adult group. The overall device survival rates were more than 96% at 10 years and 91% at 20 years. The median postoperative follow-up was 16.3 years. Moreover, a highly significant correlation was observed (r = 0.669, < 0.0001) between pure tone average (PTA) thresholds at implant activation and those at the last follow-up, as analyzed using Pearson's correlation coefficient.
CONCLUSIONS: The CI is a lifelong device; however, the technology is constantly evolving. Therefore, careful patient counseling (or counseling of parents in the case of pediatric patients) is necessary. The device may wear out over time, requiring revision surgery. These data are essential for audiologists and ENT specialists when selecting patients and determining surgical indications.

Keywords

References

  1. Otol Neurotol. 2013 Feb;34(2):259-65 [PMID: 23303172]
  2. Audiol Res. 2022 Dec 21;13(1):1-11 [PMID: 36648922]
  3. Cochlear Implants Int. 2018 Nov;19(6):297-306 [PMID: 30157714]
  4. Otol Neurotol. 2008 Feb;29(2):214-20 [PMID: 18223449]
  5. Otol Neurotol. 2023 Mar 1;44(3):e155-e159 [PMID: 36649486]
  6. Eur Arch Otorhinolaryngol. 2022 Oct;279(10):4719-4725 [PMID: 35032205]
  7. Otol Neurotol. 2005 Jul;26(4):815-8 [PMID: 16015190]
  8. Otolaryngol Head Neck Surg. 2019 Oct;161(4):688-693 [PMID: 31159704]
  9. Acta Otorhinolaryngol Ital. 2021 Dec;41(6):566-571 [PMID: 34928268]
  10. Eur Arch Otorhinolaryngol. 2022 Mar;279(3):1211-1220 [PMID: 33813626]
  11. Eur Arch Otorhinolaryngol. 2021 Mar;278(3):675-682 [PMID: 32556785]
  12. Cochlear Implants Int. 2020 Jul;21(4):228-237 [PMID: 32156201]
  13. Laryngoscope. 2020 Mar;130(3):782-789 [PMID: 31112331]
  14. Ann Otol Rhinol Laryngol. 1991 Sep;100(9 Pt 1):708-11 [PMID: 1952660]
  15. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Jun;131(3):177-82 [PMID: 24889283]
  16. Otol Neurotol. 2014 Sep;35(8):1366-72 [PMID: 24643029]
  17. Arch Otolaryngol Head Neck Surg. 2005 Mar;131(3):245-50 [PMID: 15781766]
  18. Otolaryngol Head Neck Surg. 2024 Oct;171(4):1140-1147 [PMID: 38716795]
  19. Eur Arch Otorhinolaryngol. 2016 Mar;273(3):621-9 [PMID: 25814389]
  20. Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Sep;137 Suppl 1:S45-S49 [PMID: 32826202]
  21. Otol Neurotol. 2021 Mar 1;42(3):408-413 [PMID: 33351564]
  22. Eur Arch Otorhinolaryngol. 2007 Jan;264(1):3-7 [PMID: 17009020]
  23. Laryngoscope. 2014 Oct;124(10):2393-9 [PMID: 24550135]
  24. JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):414-420 [PMID: 32134441]
  25. Acta Otolaryngol. 2009 Apr;129(4):380-4 [PMID: 19031298]
  26. Otol Neurotol. 2013 Jan;34(1):61-5 [PMID: 23202149]
  27. Eur Arch Otorhinolaryngol. 2023 Feb;280(2):929-933 [PMID: 36271955]
  28. Am J Otolaryngol. 2024 Jan-Feb;45(1):104050 [PMID: 37741025]
  29. Auris Nasus Larynx. 2013 Dec;40(6):525-9 [PMID: 23827755]

Word Cloud

Created with Highcharts 10.0.0failuredeviceimplantyearsrevisionstudyCIpatientssurgeryfollow-upsurvivalcorrelationgroupaudiologicaloutcomescochlear10Deviceanalyzedusingratesexplantstimecomparisonsdatamajorpostoperativerateduehardsoft0counselingPURPOSE:purposeevaluateclinicallong-termusersfocusinghearingperformancefailuresMETHODS:retrospectiveconductedunderwentminimumKaplan-Meiercurvesclassifiedmedical-relatedcausesreimplantationassessedStatisticalanalysesincludedPearsonStudent's-testlog-ranktestamongbrandsRESULTS:total211CIscollectedFourteencomplicationsreportedseriesresultingglobalcomplication66%:52%14%medicalproblems41%children's10%adultoverall96%91%20median163Moreoverhighlysignificantobservedr=669<0001puretoneaveragePTAthresholdsactivationlastPearson'scoefficientCONCLUSIONS:lifelonghowevertechnologyconstantlyevolvingThereforecarefulpatientparentscasepediatricnecessarymaywearrequiringessentialaudiologistsENTspecialistsselectingdeterminingsurgicalindicationsLong-TermOutcomesFollowingCochlearImplantation:"Aging"HearingPerformancedeafnessotologyotosurgery

Similar Articles

Cited By